SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-17-007143
Filing Date
2017-11-20
Accepted
2017-11-20 08:00:53
Documents
3
Period of Report
2017-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_112017.htm 6-K 10961
2 EXHIBIT 99.1 exh_991.htm EX-99.1 10352
3 GRAPHIC image_001.jpg GRAPHIC 5644
  Complete submission text file 0001171843-17-007143.txt   30234
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 171212645
SIC: 2834 Pharmaceutical Preparations